Methods for reprogramming stem or differentiated cells into hemogenic and/or hematopoietic stem cell-like cells by expressing transcription factors in a polycistronic vector.

Treatment or diagnosis of blood disorders, cancer (especially haematological tumours) or infectious diseases.